“Achiziționarea medicamentelor necesare tratamentului pacienţilor cu Hemofilie în scopul realizării Programului Național „Combaterea maladiilor rare” pentru anul 2023”

Enquiry period

with 07.09.2022 14:38
to 24.09.2022 17:27

Bidding period

with 24.09.2022 17:27
to 20.10.2022 11:00

Auction

will not be used

Evaluation

Contract

Status Evaluation

Estimated value without VAT 31 594 054,22 MDL

Period of clarifications: 7 Sep 2022, 14:38 - 24 Sep 2022, 17:27

Submission of proposals: 24 Sep 2022, 17:27 - 20 Oct 2022, 11:00

Supplier technical support:

(+373) 79999801

This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Description
Clarifications (1)

“Achiziționarea medicamentelor necesare tratamentului pacienţilor cu Hemofilie în scopul realizării Programului Național „Combaterea maladiilor rare” pentru anul 2023”

Information about customer

Title

CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE

Fiscal code/IDNO

1016601000212

Address

MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3

Web site

---

The contact person

Full name

Macari Doina

Contact phone

+37322222490

E-mail

doina.macari@capcs.md

Purchase data

Date created

7 Sep 2022, 14:13

Date modified

16 Sep 2022, 17:42

Achizitii.md ID

21063043

MTender ID

ocds-b3wdp1-MD-1662549183076

CPV

33600000-6 - Produse farmaceutice

Type of procedure

Open tender

Award criteria

The lowest price

Funding sources

20047099

List of lots

Factor Willebrand 500 UI ( IOnco)

Budget: 2580020.18 MDL

Purchase has not taken place

Go to lot

Factor Willebrand 500 UI/ Factor VIII de coagulare 500 UI Factor Willebrand 500 UI/ Factorul VIII de coagulare 500UI ( IOnco)

Budget: 2580020.18 MDL

Active

Go to lot

Factor Willebrand 1200 UI/ Factor VIII de coagulare 500 UI ( IOnco)

Budget: 1290010.09 MDL

Active

Go to lot

Cyclosporinum 100 mg

Budget: 186195.67 MDL

Purchase has not taken place

Go to lot

Factor IX de coagulare 1000 UI

Budget: 3174592.74 MDL

Active

Go to lot

Factor IX de coagulare 500 UI

Budget: 1013840.0 MDL

Active

Go to lot

Factor VIII de coagulare 1000 UI

Budget: 11639388.1 MDL

Active

Go to lot

Factor VIII de coagulare 500 UI

Budget: 529920.0 MDL

Active

Go to lot

Factor Willebrand 500 UI

Budget: 4300033.63 MDL

Purchase has not taken place

Go to lot

Factor Willebrand 500 UI/ Factor VIII de coagulare 500 UI Factor Willebrand 500 UI/ Factorul VIII de coagulare 500UI

Budget: 4300033.63 MDL

Active

Go to lot

Documents of the procurement procedure

Scrisoare de garantie bancara_Model

Bidding Documents

Scrisoare Oe

7.09.22 14:38

DUAE Model

Bidding Documents

Duae model

7.09.22 14:38

Declaratie beneficiari efectivi_Model

Bidding Documents

Declaratie OE

7.09.22 14:38

Documentatia standard.signed

Bidding Documents

Documentația standard

7.09.22 14:38

Declaratie privind valabilitatea ofertei_Model

Bidding Documents

Declaratie OE

7.09.22 14:38

contract model PN

Bidding Documents

contract model

7.09.22 14:38

Cerere de participare_Model

Bidding Documents

Cerere de participare

7.09.22 14:38

Propunerea tehnică din 04.10.2022.xlsx

Technical Specifications

Propunerea tehnică din 04.10.2022.xlsx

6.10.22 14:17

Propunerea financiară din 04.10.2022.xlsx

Technical Specifications

Propunerea financiară din 04.10.2022.xlsx

6.10.22 14:19

Anunt de participare din 04.10.2022.signed.pdf

Bidding Documents

Anunt de participare din 04.10.2022.signed.pdf

6.10.22 14:20

Date:

16 Sep 2022, 17:42

Question's name:

Specificatie tehnica la lotul Nr. 7

Question:

Solicitam modificarea specificației tehnice pentru lotul nr. 7 și anume - extinderea dozei de Factor Willebrand din "Factor Willebrand 500 UI/ Factor VIII de coagulare 500 UI" la "Factor Willebrand 500-1200 UI/ Factor VIII de coagulare 500 UI" ce va permite participarea mai multor ofertanți.

Answer (22 Sep 2022, 17:27):

Buna ziua, vor fi operate modificări, mulțumim pentru clarificare,

Only authorized platform users may ask questions during the clarification period.